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Objective. To compare quality of life in head and neck cancer (HNC) patients following treatment. Methods. The Short Form-36
Version 2 (SF-36v2) was utilized to measure patient quality of life. Results. For all 8 parameters measured by the SF-36V2, HNC
patients had lower mean scores than the US population means. Support group patients had significantly worse scores than US
population norms in role-physical, social functioning, and role-emotional. There were no significant differences between support
group and control patients for the 8 parameters measured by the SF-36v2. Conclusions. HNC patients report significantly worse
quality of life than US population norms in several physical and emotional areas. Our study did not demonstrate improved quality
of life for support group patients. The increased incidence of oropharyngeal cancer and chemotherapy treatment in the support
group patients in our study were factors which were likely to have lowered the overall scores in these patients.
1. Introduction
Approximately 43,000 new cases of head and neck cancer
(HNC) are diagnosed each year in the United States. Despite
changes in treatment regimens (i.e., organ preservation
protocols and the addition of chemotherapy to primary
radiation treatment), survival curves have not changed over
the past 20 years. In this setting, there has been an increasing
interest in trying to understand andmaximize patient quality
of life (QOL).
Quality of life is a subjective perception by the patient
that includes physical, emotional, and social well-being. It
is well-established that different subsites within the head
and neck have different perceived QOL following treatment;
patients with oropharyngeal carcinoma tend to report worse
quality of life than do other head and neck cancer patients
and have poorer functional outcomes [1, 2]. Furthermore,
specific aspects of treatment greatly affect a patient’s quality
of life. Terrell et al. identified a number of factors that have a
negative impact on QOL including need for gastrostomy and
tracheostomy tubes, comorbid medical conditions, addition
of chemotherapy to treatment, and need for a neck dissection
[3].
A variety of mechanisms have been proposed in the liter-
ature to improve patient quality of life, including educational
programs, support groupmeetings, biofeedback therapy, and
cognitive behavioral therapy. However, the impact of these
interventions has not been extensively studied in head and
neck cancer patients.
Support group therapy is a well-established means
of psychosocial intervention in the cancer literature. The
majority of research regarding support groups comes from
the breast cancer literature. However, only a handful of
studies regarding support group therapy in the head and
neck population exist, and the results are mixed [4, 5].
The current study was designed to compare HNC patients
who participate in a support group to those who do not
participate in a support group. These two groups were then
combined and compared to normative US population data.
We hypothesized that HNC support group patients would
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do better than their peers who do not participate and that
both groups would have lower QOL scores than the US
population.
2. Methods and Patients
The Institutional Review Board for Human Subjects at UCLA
approved this study (IRB # G06-11-050-01). Patients were
recruited in two ways: (1) directly from Support for People
with Oral and Head and Neck Cancer (SPOHNC) support
group meetings or (2) during cancer surveillance follow-up
appointments in the clinic of a tertiary referral center. All
patients were provided informed consent and a completed
questionnaire implied their consent to participate in the
study.
Support for People with Oral and Head and Neck
Cancer (SPOHNC) is a nonprofit organization run by HNC
survivors to help other patients learn more about and
cope with their disease. Local chapters sponsor support
group meeting across the country. The chapter of SPOHNC
affiliated with our institution is organized by a clinical social
worker who also facilitates the support group discussions.
Patients were asked to fill out the Medical Outcomes
Study Short Form-36 Item Health Survey version 2 (SF-
36v2, Quality Metric, Inc., Lincoln, RI) which asks questions
regarding 8 domains related to global QOL. The domains
investigated by this instrument are physical functioning (PF),
role-physical (RF), bodily pain (BP), general health (GH),
vitality (VT), social functioning (SF), role-emotional (RE),
and mental health (MH). The instrument consists of 36
questions arranged in 8 sections. A higher subscale score
represents a better perceived quality of life. Scores can range
from 0 (very poor quality of life) to 100 (excellent quality
of life). The PF domain measures ability to do specific
activities, such as walking 100 yards or bathing oneself.
The RP domain queries how any physical limitations have
impacted the patient’s life, such as cutting back on work
hours or accomplishing less than expected. Bodily pain (BP)
asks about the amount of pain and if it has limited activity.
The general health (GH) domain measures the patient’s
perception of their health; questions include a rating of their
health from excellent to poor. Other questions in this domain
ask the patient to compare their health to others and their
expectations for their health. Vitality (V) queries the patient’s
perception of their energy level, such as full of energy to
“worn out.” Social functioning (SF) measures how much
health-related issues have interfered with social activity.
The role emotional (RE) domain asks the patient to assess
how much these health-related issues have impacted the
performance of activities. Mental health (MH) asks questions
regarding anxiety and depression. The final question of the
instrument asks the respondent to compare their current
status to their health one year ago.
Scoring of the SF-36v2 questionnaires was done accord-
ing to the method previously described [6]. A supplemental
questionnaire, designed by the authors, was also included,
which asked patients to self-report the type and location
of cancer, method of treatment, and time since completion
Table 1: Cohort characteristics.
Support group
cohort
Cancer control
cohort
P value
Age 60.9 61.4 0.71
Sex (M/F in %) 40/60 50/50 0.55
Location 45% oropharynx 68% oral cavity 0.0036
Time since
treatment
(in years)
4.4 0.8 0.079
of treatment. Patients were allowed to write any comments
they wanted on this supplemental form. Data obtained from
the questionnaires was then entered into a Microsoft Excel
spreadsheet which was programmed to perform conversion
calculations as described by the scoring instructions. SDSS
software was then used to perform statistical analysis of
the data. Two sets of data were generated: one comparing
cancer patients to 1998 US norms and another comparing
the different cancer groups to each other. When comparing
cancer groups, both unadjusted and adjusted measurements
were calculated. Adjustments were made for elapsed time
since the end of treatment (in years), cancer therapies
(including surgery, radiotherapy, and chemotherapy), and
cancer location (oral cavity/oropharynx/other and larynx).
A 1-sample t-test was performed to determine if the mean
score differed significantly from the US norms. In the
case of sparse data, the Fisher exact test was used to
compare categorical variables with 2 levels and Monte Carlo
simulation to compare categorical variables with more than
2 levels. Missing values were imputed using the average score
based on questions that were answered on the corresponding
SF-36v2 scale, but only if at least 50% of the questions were
answered. Otherwise, the scale score was considered missing.
3. Results
A total of 37 patients completed the SF-36v2, 21 from the
support group and 16 from the nonsupport group. Within
the support group category, 12 were female (60%) and
the average age was 61 years old. There was a statistically
significant difference between the two groups as to the loca-
tion of their primary tumor. Forty-five percent of patients
in the support group reported an oropharyngeal primary
site, while 68% of nonsupport group patients reported an
oral cavity primary site (P = 0.0036). Both groups had
undergone multimodality therapy; there was no statistically
significant difference between the groups as to the type
of therapy rendered (most patients had undergone surgery
and/or radiation therapy with or without chemotherapy)
(Table 1). Because the patients provided the information
regarding their treatment regimens, specific data regarding
radiotherapy dosing and exact chemotherapeutic regimens
was not available.
3.1. All HNC Patients versus US Normative Values. All
values for HNC patients were lower than the 1998 US
normative values. However, only 4 domains were statistically
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Table 2: Comparison with US normative values and cancer cohorts.
Domain US norms (Z scores)
All cancer patients
(standard normal
distribution = Z
score)
P values (all cancer
versus US norms)
Support group
patients (mean Z
scores)
P values (support
group versus US
norms)
Role physical 82.51 60.47 0.0087 56.85 0.006
Physical function 83.29 71.36 0.0003 71.19 0.058
Social function 84.30 67.47 0.0015 67.26 0.013
Role emotional 87.40 68.47 0.0005 63.10 0.003
General health 70.85 64.78 0.101 60.4 0.061
Table 3: Comparison of support group cohort versus nonsupport
group patients.
Domain
Support group
Mean Z score
Control group
Mean Z score
Parametric
P value
PF 71.19 71.60 0.963
RP 56.85 65.23 0.454
BP 60.62 67.63 0.526
GH 60.40 70.25 0.178
VT 55.36 60.27 0.557
SF 67.26 67.97 0.944
RE 63.1 75.52 0.222
MH 68.81 76.88 0.239
significantly different: physical function, role physical, social
function, and role emotional (P = 0.0087, 0.003, 0.0015,
and 0.0005, resp.). For role physical, social function, and role
emotional, greater than 20% of respondents reported scores
2 standard deviations below the 1998 normative means
(Table 2). Furthermore, when analyzed separately, support
group patients did significantly worse than US norms for
physical function, role physical, social function, general
health, and role emotional (Table 2).
3.2. Support Group Patients versus Cancer Control Patients.
There were 21 patients in the support group cohort and
16 patients in the control cohort. There was no statistically
significant difference for any domain between the two
groups nor did any domain approach statistical significance
(Table 3). As noted above, there were significant differences
between the two groups with regard to primary cancer
subsite.
4. Discussion
The diagnosis of head and neck cancer has a profound effect
on patients. They are affected physically, emotionally, and
socially; all of which lead to a change in their perceived
global quality of life. In this study, we failed to find a
statistically significant improvement in patients’ perceived
QOL when they participate in a head and neck cancer-
specific support group. However, many support group
participants anecdotally related the comfort they received by
being able to speak to others who have very similar concerns
and problems. While this aspect of the support group did
not appear to impact their overall QOL, it is obviously
important to many participants to feel they were not alone.
Not surprisingly, cancer survivors reported decreased quality
of life for all domains; however, only about half of the queried
domains were statistically significantly lower.
The support group at our institution is sponsored by
SPOHNC. The local chapter of this national group provides
a monthly forum for discussion. These meetings are held at
the hospital, and medical professionals are frequently invited
to come to the discussion to talk about recent advances in
head and neck cancer or treatment-related issues. This group
has been active for a number of years at our institution and
participants in the study were recruited directly from the
meeting by the authors. A number of the group participants
have been regularly active members for many years, while
others were relatively new to the support group forum.
Therefore, the range of time from treatment to questionnaire
was highly variable in the support group cohort of this
study. However, we feel that recruiting patients directly
from a previously constituted support group may more
accurately reflect the effect of the support group on those
who participate. Other studies in the literature have looked
at the QOL of patients who were asked to participate in a
support group. Two previous studies created support groups
for the patients to participate in, rather than drawing data
from patients in preexisting support groups [4, 5].
The literature regarding the effect of support group
therapy on head and neck patients is somewhat sparse, but
there is a fairly large body of work regarding support group
participation in patients with breast, lung, and colon cancer.
Support groups have been found to decrease anxiety and
depression [7]. While the results in other cancer groups
demonstrate substantial improvement in patients’ perceived
QOL, our study failed to find a significant difference in QOL
outcomes between head and neck support group participants
and nonparticipants. This finding was unexpected. Several
explanations may exist for this lack of difference. First,
perhaps the difference in cancer subsite affected the outcome.
Support group participants were more likely to have oropha-
ryngeal carcinoma, while nonparticipants were more likely
to have oral tongue lesions. It is generally agreed that patients
with oropharyngeal carcinoma have somewhat poorer QOL
outcomes than other subsites. Thus, this bias toward poorer
outcomes may have negated the positive effect of the support
group on their QOL. The second explanation may lie with
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the fact that the study group was drawn from a preexisting
support group. We did not test for underlying depressive
disorders or question patients regarding their psychological
coping mechanisms. Perhaps those patients who participate
regularly in a support group lack some of these coping
mechanisms and therefore need the psychological support
of the group more than their nonparticipating counterparts.
Further research into the area is necessary to determine if
support group therapy would benefit specific cancer subsite
patients differently. It is also possible that different subsites
of head and neck cancer require different methods or
styles of supportive therapy. Lastly, perhaps the choice of
instrument affected the ability to detect a difference in the
two groups. The SF-36v2 is a general health questionnaire.
It is possible that a head and neck specific instrument, such
as the University of Washington or University of Michigan
instruments, may be more sensitive in detecting differences
between these two cohorts.
With regard to the comparison between the cancer
patients and US normative values, the results were less
surprising. Cancer patients scored lower on the SF-36v2 than
US norms; however, there were only 4 domains where this
decrement was statistically significant. The domains most
affected by cancer were physical function, role physical, social
function, and role emotional.
The SF-36v2 instrument has been used in a number of
other studies in the head and neck literature. Netscher et al.
evaluated the quality of life in patients who had undergone
microvascular free flap reconstruction after ablative surgery
for advanced oropharyngeal carcinoma [8]. When compared
to US norms, these patients had poor perceived quality of life
both before and 1 year after surgery with regard to ability to
work, vitality, social function, and emotional function. These
are the same domains that were significantly lower in our
study as well.
This study is limited in several ways. First, there were
a small number of participants in the support group
cohort. This problem was inherent to the study design, as
participants were recruited from an already existing support
group, rather than being invited to participate in the group.
There are several other SPOHNC groups in the Los Angeles
area, and further studies with other support groups may be
possible. Secondly, the two cancer patient cohorts were sta-
tistically different with regard to their composition. However,
patients were asked to participate without knowledge of their
subsite of cancer. Further studies would need subsite and age-
matched controls in order to remove this source of bias. It
is possible that the preponderance of oropharyngeal cancer
patients in the support group cohort diminished the scores in
this group and thus negated any SF-36v2 score improvement
in this cohort.
5. Conclusions
We failed to demonstrate an improvement in the perceived
quality of life of head and neck cancer patients who
participate in a head and neck specific support group when
compared to those HNC patients who do not participate.
However, the camaraderie that exists within a support group
may be important to those who do participate and should
not be discouraged. Not surprisingly, HNC patients have
poorer perceived quality of life when compared to the
US population. Further research into ways to improve our
patients’ posttreatment QOL is important, and further study
into support groups or educational programs is warranted.
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